Frankfurt - Delayed Quote EUR

BrainCool AB (publ) (5YL.F)

Compare
0.1238 +0.0004 (+0.32%)
As of 9:15 AM GMT+1. Market Open.
Loading Chart for 5YL.F
DELL
  • Previous Close 0.1234
  • Open 0.1238
  • Bid 0.1260 x --
  • Ask 0.1576 x --
  • Day's Range 0.1238 - 0.1238
  • 52 Week Range 0.0966 - 0.4900
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 35.937M
  • Beta (5Y Monthly) 1.65
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers products for medical cooling treatments for a range of diseases, including stroke, sudden cardiac arrest, oral mucositis, and migraine. It provides BrainCool and RhinoChill systems that facilitates rapid medical cooling treatment in an emergency setting and ensures the continuum of care; Cooral system provides medical professionals an easy way to reduce the risk of oral mucositis; and IQool system offers an easy-to-use intuitive interface, informative graphics, and an automatic feedback loop allowing clinicians to manage their patient rather than a device. The company was incorporated in 2010 and is based in Lund, Sweden.

braincoolinc.com

20

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 5YL.F

View More

Performance Overview: 5YL.F

Trailing total returns as of 11/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

5YL.F
71.86%
OMX Stockholm 30 Index
3.23%

1-Year Return

5YL.F
68.34%
OMX Stockholm 30 Index
12.58%

3-Year Return

5YL.F
79.22%
OMX Stockholm 30 Index
4.32%

5-Year Return

5YL.F
85.41%
OMX Stockholm 30 Index
12.80%

Compare To: 5YL.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 5YL.F

View More

Valuation Measures

Annual
As of 11/18/2024
  • Market Cap

    34.93M

  • Enterprise Value

    33.55M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.66

  • Price/Book (mrq)

    2.35

  • Enterprise Value/Revenue

    10.36

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -141.57%

  • Return on Assets (ttm)

    -19.50%

  • Return on Equity (ttm)

    -39.83%

  • Revenue (ttm)

    40.67M

  • Net Income Avi to Common (ttm)

    -57.58M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    41.27M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -50.66M

Research Analysis: 5YL.F

View More

Company Insights: 5YL.F

Research Reports: 5YL.F

View More

People Also Watch